List of Contents

Electrophysiology Devices Market Size, Share, and Trends 2024 to 2034

The global electrophysiology devices market size is estimated at USD 14.55 billion in 2025 and is anticipated to reach around USD 49.80 billion by 2034, expanding at a CAGR of 14.69% from 2025 to 2034. The North America electrophysiology devices market size is evaluated at USD 6.20 billion in 2024 and is expanding at a CAGR of 14.72% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : January 2025
  • Report Code : 1100
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Electrophysiology Devices Market, By Indication

7.1. Electrophysiology Devices Market, by Indication Type, 2025-2034
7.1.1. Atrial Fibrillation (AF)
7.1.1.1. Market Revenue and Forecast (2022-2034)
7.1.2. Atrioventricular Nodal Re-entry Tachycardia (AVNRT)
7.1.2.1. Market Revenue and Forecast (2022-2034)
7.1.3. Supraventricular Tachycardia
7.1.3.1. Market Revenue and Forecast (2022-2034)
7.1.4. Bradycardia
7.1.4.1. Market Revenue and Forecast (2022-2034)
7.1.5. Wolff-Parkinson-White Syndrome (WPW)
7.1.5.1. Market Revenue and Forecast (2022-2034)
7.1.6. Others
7.1.6.1. Market Revenue and Forecast (2022-2034)

Chapter 8. Global Electrophysiology Devices Market, By Application

8.1. Electrophysiology Devices Market, by Application, 2025-2034
8.1.1. Diagnostic Devices
8.1.1.1. Market Revenue and Forecast (2022-2034)
8.1.2. Treatment Devices
8.1.2.1. Market Revenue and Forecast (2022-2034)

Chapter 9. Global Electrophysiology Devices Market, By End-User

9.1. Electrophysiology Devices Market, by End-User, 2025-2034
9.1.1. Ambulatory Surgical Centers
9.1.1.1. Market Revenue and Forecast (2022-2034)
9.1.2. Hospitals
9.1.2.1. Market Revenue and Forecast (2022-2034)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2022-2034)

Chapter 10. Global Electrophysiology Devices Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue and Forecast, by Indication (2022-2034)
10.1.2. Market Revenue and Forecast, by Application (2022-2034)
10.1.3. Market Revenue and Forecast, by End-User (2022-2034)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Indication (2022-2034)
10.1.4.2. Market Revenue and Forecast, by Application (2022-2034)
10.1.4.3. Market Revenue and Forecast, by End-User (2022-2034)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Indication (2022-2034)
10.1.5.2. Market Revenue and Forecast, by Application (2022-2034)
10.1.5.3. Market Revenue and Forecast, by End-User (2022-2034)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Indication (2022-2034)
10.2.2. Market Revenue and Forecast, by Application (2022-2034)
10.2.3. Market Revenue and Forecast, by End-User (2022-2034)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Indication (2022-2034)
10.2.4.2. Market Revenue and Forecast, by Application (2022-2034)
10.2.4.3. Market Revenue and Forecast, by End-User (2022-2034)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Indication (2022-2034)
10.2.5.2. Market Revenue and Forecast, by Application (2022-2034)
10.2.5.3. Market Revenue and Forecast, by End-User (2022-2034)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Indication (2022-2034)
10.2.6.2. Market Revenue and Forecast, by Application (2022-2034)
10.2.6.3. Market Revenue and Forecast, by End-User (2022-2034)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Indication (2022-2034)
10.2.7.2. Market Revenue and Forecast, by Application (2022-2034)
10.2.7.3. Market Revenue and Forecast, by End-User (2022-2034)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Indication (2022-2034)
10.3.2. Market Revenue and Forecast, by Application (2022-2034)
10.3.3. Market Revenue and Forecast, by End-User (2022-2034)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Indication (2022-2034)
10.3.4.2. Market Revenue and Forecast, by Application (2022-2034)
10.3.4.3. Market Revenue and Forecast, by End-User (2022-2034)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Indication (2022-2034)
10.3.5.2. Market Revenue and Forecast, by Application (2022-2034)
10.3.5.3. Market Revenue and Forecast, by End-User (2022-2034)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Indication (2022-2034)
10.3.6.2. Market Revenue and Forecast, by Application (2022-2034)
10.3.6.3. Market Revenue and Forecast, by End-User (2022-2034)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Indication (2022-2034)
10.3.7.2. Market Revenue and Forecast, by Application (2022-2034)
10.3.7.3. Market Revenue and Forecast, by End-User (2022-2034)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Indication (2022-2034)
10.4.2. Market Revenue and Forecast, by Application (2022-2034)
10.4.3. Market Revenue and Forecast, by End-User (2022-2034)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Indication (2022-2034)
10.4.4.2. Market Revenue and Forecast, by Application (2022-2034)
10.4.4.3. Market Revenue and Forecast, by End-User (2022-2034)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Indication (2022-2034)
10.4.5.2. Market Revenue and Forecast, by Application (2022-2034)
10.4.5.3. Market Revenue and Forecast, by End-User (2022-2034)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Indication (2022-2034)
10.4.6.2. Market Revenue and Forecast, by Application (2022-2034)
10.4.6.3. Market Revenue and Forecast, by End-User (2022-2034)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Indication (2022-2034)
10.4.7.2. Market Revenue and Forecast, by Application (2022-2034)
10.4.7.3. Market Revenue and Forecast, by End-User (2022-2034)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Indication (2022-2034)
10.5.2. Market Revenue and Forecast, by Application (2022-2034)
10.5.3. Market Revenue and Forecast, by End-User (2022-2034)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Indication (2022-2034)
10.5.4.2. Market Revenue and Forecast, by Application (2022-2034)
10.5.4.3. Market Revenue and Forecast, by End-User (2022-2034)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Indication (2022-2034)
10.5.5.2. Market Revenue and Forecast, by Application (2022-2034)
10.5.5.3. Market Revenue and Forecast, by End-User (2022-2034)

Chapter 11. Company Profiles

11.1. Medtronic Plc
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Abbot Laboratories
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Boston Scientific Corporation
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Biotronik SE & CO. KG
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Biosense Webster, Inc.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Nihon Kohden Corporation
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. GE Healthcare
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Microport Scientific Corporation
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Siemens AG
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Koninklijke Philips N.V.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

As per Precedence Research, the global electrophysiology devices market size is expected to be worth around USD 49.80 bn by 2034.

The global electrophysiology devices market is poised to grow at a CAGR 14.69% over forecast period 2025 to 2034.

Increasing application of electrophysiology devices in the treatment and diagnosis of cardiovascular diseases that includes atrial fibrillation, rising demand for cardiac rhythm management devices used for continuous monitoring and increasing implementation of these devices in out-of-hospital settings are some of the high impact rendering growth drivers for the market. Growing prevalence of cardiac arrest and heart failure (HF) cases among the millennial owing to lifestyle habits such as excessive alcohol consumption and smoking is the other major factor that propels the market growth.

North America dominated the global market in the year 2024 owing to technological advancements in the healthcare industry along with favorable government support.

The Asia Pacific exhibits the fastest growth over the forecast period owing to significant presence of untapped opportunities in reference to unmet medical requirements along with rapid growth in the incidence rates of target diseases.

Diagnostic devices application segment accounted for the largest value share in 2024 attributed to significant application of cardiac monitors as a standard monitoring and diagnostic tool for arrhythmias.

Atrial fibrillation leads the indication segment in the global electrophysiology devices market for the year 2024.

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us